Sanofi-Aventis's Prowl for New Insulin, Could it be Biodel's Linjeta?

publication date: Sep 28, 2010

Last week, Sanofi-Aventis (NYSE: SNY) confirmed that it is on the prowl for diabetes partnerships. Bloomberg reported statements made by Riccardo Perfetti, the Senior Medical Director for Sanofi-Aventis’ diabetes unit, that Sanofi-Aventis may unveil...

Sorry this page is available to subscribers only. If you're not a subscriber why not join today?

You can also sign up for our 100% FREE Newsletter to stay current on public webinars, special offers, and news alerts: